Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Preliminary clinical and laboratory observations suggest that nifedipine might prevent progression of threatened myocardial infarction by reversing coronary spasm or might limit necrosis during the course of acute myocardial infarction. We screened 3143 patients with ischemic pain of greater than 45 min duration and randomly assigned 105 eligible patients with threatened myocardial infarction and 66 with acute myocardial infarction to receive nifedipine (20 mg orally every 4 hr for 14 days) or placebo plus standard care. Treatment was started 4.6 +/- 0.1 hr after the onset of pain. Infarct size index was calculated by the MB-creatine kinase (CK) method and expressed as CK-geq/m2 +/- SE. The incidence of progression to infarction among patients with threatened myocardial infarction was not significantly altered by nifedipine (36 of 48 [75%] for placebo-treated and 43 of 57 [75%] for nifedipine-treated patients). Furthermore, infarct size index was similar among placebo- and nifedipine-treated patients (16.9 +/- 1.5 MB-CK-geq/m2, n = 65, and 17.0 +/- 1.5 MB-CK-geq/m2, n = 68, respectively) with threatened myocardial infarction who exhibited infarction and for those with acute myocardial infarction. Among the 171 eligible patients randomly assigned to drug or placebo, 6 month mortality did not differ significantly (8.5% for placebo vs 10.1% for nifedipine, NS), but mortality in the 2 weeks after randomization was significantly higher for nifedipine-treated patients (0% for placebo compared with 7.9% for nifedipine, p = .018).(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applied Nonparametric Statistics
Wozniak, P. J., & Daniel, W. W. (1991) · Technometrics · doi:10.2307/1268795 · Cited by 4,987
Siegel, S. (1957) · The American Statistician · doi:10.1080/00031305.1957.10501091 · Cited by 3,903
Treatment of myocardial infarction in a coronary care unit.
Lf, T., Berman, D. A., Goldfarb, B., Mb, S., & Berman, R. S. (1969) · PubMed · Cited by 1,611
Maseri, A., L'Abbate, A., Baroldi, G., Chierchia, S., Marzilli, M., Ballestra, A. M., Severi, S., Parodi, O., Biagini, A., Distante, A., et al. (1978) · New England Journal of Medicine · doi:10.1056/nejm197812072992303 · Cited by 843
A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial Infarction
Anderson, J. L., Marshall, H. W., Bray, B. E., Lutz, J. R., Frederick, P. R., Yanowitz, F. G., Datz, F. L., Klausner, S. C., & Hagan, A. D. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306023082202 · Cited by 531
Arteriographic evidence of coronary arterial spasm in acute myocardial infarction.
Oliva, P. B., & Breckinridge, J. C. (1977) · Circulation · doi:10.1161/01.cir.56.3.366 · Cited by 517
Nifedipine Therapy for Coronary-Artery Spasm: Experience in 127 Patients
Antman, E., Muller, J., Goldberg, S., MacAlpin, R., Rubenfire, M., Tabatznik, B., Liang, C.-S., Heupler, F., Achuff, S., Reicher, N., et al. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006053022301 · Cited by 423
Self-citationKhaja, F., Walton, J. A., Brymer, J. F., Lo, E., Osterberger, L., O'Neill, W. W., Colfer, H. T., Weiss, R., Lee, T., Kurian, T., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306023082201 · Cited by 379
An improved basis for enzymatic estimation of infarct size.
Roberts, R., Henry, P. D., & Sobel, B. E. (1975) · Circulation · doi:10.1161/01.cir.52.5.743 · Cited by 351
Self-citationAndersen, M., Frederiksen, J., Jürgensen, H., Pedersen, F., Bechsgaard, P., Hansen, D., Nielsen, B., Pedersen-Bjergaard, O., & Rasmussen, S. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92684-9 · Cited by 227
Cited by
Heart rate variability: A review
Rajendra Acharya, U., Paul Joseph, K., Kannathal, N., Lim, C. M., & Suri, J. S. (2006) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-006-0119-0 · Cited by 2,820
“In normotensive adults, the beta-adrenergic blocker atenolol appears to augment vagally mediated fast fluctuations in HR [79].”
BackgroundACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
Nifedipine: Dose-Related Increase in Mortality in Patients With Coronary Heart Disease
Furberg, C. D., Psaty, B. M., & Meyer, J. V. (1995) · Circulation · doi:10.1161/01.cir.92.5.1326 · Cited by 1,173
The Framingham Offspring Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Kompendium der Lipid-Studien · doi:10.1007/978-3-642-95642-3_25 · Cited by 831
The Effect of Diltiazem on Mortality and Reinfarction after Myocardial Infarction
The Multicenter Diltiazem Postinfarction Trial Research Group* (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190701 · Cited by 825
Califf, R. M., Adams, K. F., McKenna, W. J., Gheorghiade, M., Uretsky, B. F., McNulty, S. E., Darius, H., Schulman, K., Zannad, F., Handberg-Thurmond, E., et al. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70105-4 · Cited by 665
Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial Infarction
Gibson, R. S., Boden, W. E., Theroux, P., Strauss, H. D., Pratt, C. M., Gheorghiade, M., Capone, R. J., Crawford, M. H., Schlant, R. C., Kleiger, R. E., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608143150704 · Cited by 537
Self-citationThe effect of diltiazem on mortality and reinfarction after myocardial infarction
Warnock, E. (1989) · The Journal of Emergency Medicine · doi:10.1016/0736-4679(89)90390-9 · Cited by 508
Gunnar, R. M., Bourdillon, P. D., Dixon, D. W., Fuster, V, Karp, R. B., Kennedy, J. W., Klocke, F. J., Passamani, E. R., Pitt, B., & Rapaport, E. (1990) · Circulation · doi:10.1161/01.cir.82.2.664 · Cited by 474
Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.
Held, P. H., Yusuf, S., & Furberg, C. D. (1989) · BMJ · doi:10.1136/bmj.299.6709.1187 · Cited by 426
Sorkin, E. M., Clissold, S. P., & Brogden, R. N. (1985) · Drugs · doi:10.2165/00003495-198530030-00002 · Cited by 355
Guidelines for the early management of patients with acute myocardial infarction
Gunnar, R. M., Bourdillon, P. D. V., Dixon, D. W., Fuster, V., Karp, R. B., Kennedy, J. W., Klocke, F. J., Passamani, E. R., Pitt, B., Rapaport, E., et al. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90575-a · Cited by 344
(1986) · Heart · doi:10.1136/hrt.56.5.400 · Cited by 271
Metadata
- Authors
- Muller, J. E., Morrison, J., Stone, P. H., Rude, R. E., Rosner, B., Roberts, R., Pearle, D. L., Turi, Z. G., Schneider, J. F., & Serfas, D. H.
- Venue
- Circulation
- Published
- 1984-04
- Volume
- 69
- Issue
- 4
- Pages
- 740-747
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2031232834
- Cited by
- 264
- References
- 17
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.